Metastatic papillary renal cancer has poor outcomes, and new treatments are needed. There is a strong rationale for investigating the combination of mesenchymal epithelial transition receptor (MET) ...

The combination of savolitinib and durvalumab demonstrated durable activity in a phase 2 trial of patients with papillary RCC.

In this video, Francesca Jackson-Spence,MBChB, BSc, shares data from the study, “Final overall survival and new ctDNA analysis in MET-driven advanced papillary renal cancer (CALYPSO; NCT02819596),” ...

This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...

The three most common forms of RCC are clear cell RCC, papillary RCC and chromophobe RCC. Metabolic dysregulation in the development of clear cell renal cell carcinoma (ccRCC) remains to be ...

Patient 1 was a 73-year-old woman with a 30-year history of nephrolithiasis, as well as a history of rheumatoid arthritis and arterial hypertension. She had been treated with methotrexate ...

During a Case-Based Roundtable® event, Kathryn E. Beckermann, MD, PhD, discussed second-line regimens with event participants depending on their own practice and trial data for a patient with clear ...

Most cancers are named after the part of the body where the cancer first begins, and kidney cancer is no exception. Kidney cancer begins in the kidneys—two large, bean-shaped organs—one located to the ...

This study aimed to establish relations between calcified deposits in renal papillae and the development and morphology of corresponding COM papillary renal calculi.

The tumor couldn’t be biopsied, and surgery was the only way to confirm if it was cancerous. So, on Dec. 18, 2023, Wade had a ...

ASCO Genitourinary Cancers Symposium approaches, several highly anticipated studies are set to shape the future of treatment ...